-
Vioxx Wins Again
Merck has reason to celebrate this weekend. A state appeals court in Texas overturned a $26 million jury verdict against the company in a lawsuit brought by Carol Ernst, whose husband, Robert, died in 2001 after taking Vioxx. In reversing the verdict, the appeals court found that plaintiffs had not proved that Vioxx caused Mr. ...
-
Cholesterol Drug A No-Go
The FDA denied approval of the much anticipated Merck & Co. cholesterol drug Cordaptive on Monday, stating that more information on the drug is needed, and that the trade name Cordaptive is not acceptable. Merck is also the creator of the controversial cholesterol drug Vytorin, which came under fire in January when studies showed that ...
-
End Of A Marriage
Schering-Plough and Merck have been making moves to bring their two respective allergy drugs—Claritin and and Singulair—together to form one super-drug, but it according to a recent Wall Street Journal article, it doesn’t look like that is going to happen. On April 25, the company said late the FDA had rejected an application for a ...